Xin Hang
InvestorSenior Principal at CTI Life Sciences Fund L.P.
About
Xin Hang is a Senior Principal whose Sanofi manufacturing experience and valuation work—leading forecasting for Point Biopharma’s SPAC and Horizon’s Amgen deal—combine technical and financial drug‑development expertise.
Contact· self-published, not guessed
Invests in
BiotechHealthtechMedical Devices
Colleagues at CTI Life Sciences Fund L.P.
Dana Matzen
Partner at CTI Life Sciences Fund L.P.
Ken Pastor
Managing Partner at CTI Life Sciences Fund L.P.
Laurence Rulleau
Managing Partner at CTI Life Sciences Fund L.P.
Paul Cassar
Associate at CTI Life Sciences Fund L.P.
Radhika Gupta
Principal at CTI Life Sciences Fund L.P.
Shermaine Tiley
Managing Partner at CTI Life Sciences Fund L.P.
Shermaine Tilley
Managing Partner at CTI Life Sciences Fund L.P.
Youssef Bennani
Managing Partner at CTI Life Sciences Fund L.P.
Frequently asked questions
- Who is Xin Hang?
- Xin Hang is a Senior Principal whose Sanofi manufacturing experience and valuation work—leading forecasting for Point Biopharma’s SPAC and Horizon’s Amgen deal—combine technical and financial drug‑development expertise.
- Where does Xin Hang work?
- Xin Hang is Senior Principal at CTI Life Sciences Fund L.P..
- What does Xin Hang invest in?
- Xin Hang invests in Biotech, Healthtech, Medical Devices.